vTv Therapeutics (VTVT) Interest & Investment Income (2014 - 2026)
vTv Therapeutics' (VTVT) quarterly Interest & Investment Income came in at $838000.0 in Q1 2026, up 153.17% year-on-year from $331000.0 in Q1 2025, and down 3.12% quarter-over-quarter from $865000.0 in Q4 2025.
vTv Therapeutics (VTVT) Interest & Investment Income (2014 - 2026) Analysis & Trends
vTv Therapeutics has disclosed Interest & Investment Income across 13 years of filings, most recently posting $838000.0 for Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $838000.0, up 153.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.4 million (up 30.82% YoY), and the FY2025 annual result was $1.9 million, up 19.49% from the prior year.
- Interest & Investment Income came in at $838000.0 for Q1 2026 at vTv Therapeutics, down from $865000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $865000.0 in Q4 2025 to a low of $50000.0 in Q2 2022.
- The 5-year median for Interest & Investment Income is $214000.0 (2023), against an average of $318562.5.
- Across the five-year window, Interest & Investment Income jumped 387.5% in 2024 and slumped 50.27% in 2025, its largest moves.
- vTv Therapeutics' Interest & Investment Income stood at $152000.0 in 2022, then tumbled by 42.11% to $88000.0 in 2023, then surged by 387.5% to $429000.0 in 2024, then surged by 101.63% to $865000.0 in 2025, then slipped by 3.12% to $838000.0 in 2026.
- The last three Interest & Investment Income figures came in at $838000.0 (Q1 2026), $865000.0 (Q4 2025), and $399000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | vTv Therapeutics | 426.76 Mn | 426.76 Mn | - | 838,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 838,000.00 |
| Dec 31, 2025 | 865,000.00 |
| Sep 30, 2025 | 399,000.00 |
| Jun 30, 2025 | 275,000.00 |
| Mar 31, 2025 | 331,000.00 |
| Dec 31, 2024 | 429,000.00 |
| Sep 30, 2024 | 504,000.00 |
| Jun 30, 2024 | 553,000.00 |
| Mar 31, 2024 | 79,000.00 |
| Dec 31, 2023 | 88,000.00 |
| Sep 30, 2023 | 131,000.00 |
| Jun 30, 2023 | 153,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Dec 31, 2022 | 152,000.00 |
| Sep 30, 2022 | 150,000.00 |
| Jun 30, 2022 | 50,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Mar 31, 2020 | 12,000.00 |
| Dec 31, 2019 | 12,000.00 |
| Sep 30, 2019 | 15,000.00 |